REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmatheka Consult d.o.o. (Croatia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Pharmatheka Consult d.o.o. Profile Updated: August 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Pharmatheka Consult d.o.o. is an enterprise based in Croatia. Its main office is in Poljanica Bistranska. The company operates in the Pharmaceutical Preparation Manufacturing sector. The enterprise was incorporated on December 09, 1996. It currently has a total number of 18 (2024) employees. From the latest financial highlights, Pharmatheka Consult d.o.o. reported a net sales revenue drop of 3.9% in 2024. There was a total negative growth of 1.5% in Pharmatheka Consult d.o.o.’s total assets over the same period. In, 2024, the company’s net profit margin decreased by 1.14%.

Headquarters
Bistranska 93 Str.
Poljanica Bistranska; Zagreb; Postal Code: 10298

Contact Details: Purchase the Pharmatheka Consult d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmatheka Consult d.o.o. report to view the information.
Financial Auditors:
Purchase the Pharmatheka Consult d.o.o. report to view the information.
Incorporation Date:
December 09, 1996
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Pharmatheka Consult d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-3.9%
Total operating revenue
-3.9%
Operating profit (EBIT)
-28.29%
EBITDA
-20.04%
Net Profit (Loss) for the Period
-69.92%
Total assets
-1.5%
Total equity
2.47%
Operating Profit Margin (ROS)
-0.73%
Net Profit Margin
-1.14%
Return on Equity (ROE)
-5.41%
Debt to Equity Ratio
-5.65%
Quick Ratio
-0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?